nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2B6—malignant glioma	0.841	1	CbGaD
Prasugrel—CYP3A4—Temozolomide—malignant glioma	0.0358	1	CbGbCtD
Prasugrel—Clopidogrel—CYP2B6—malignant glioma	0.00543	1	CrCbGaD
Prasugrel—Retinal haemorrhage—Carmustine—malignant glioma	0.00388	0.119	CcSEcCtD
Prasugrel—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00298	0.0913	CcSEcCtD
Prasugrel—Neoplasm—Carmustine—malignant glioma	0.00114	0.035	CcSEcCtD
Prasugrel—Neoplasm—Temozolomide—malignant glioma	0.0011	0.0339	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000918	0.0281	CcSEcCtD
Prasugrel—Haemoglobin—Carmustine—malignant glioma	0.000638	0.0196	CcSEcCtD
Prasugrel—Haemorrhage—Carmustine—malignant glioma	0.000635	0.0195	CcSEcCtD
Prasugrel—Oedema peripheral—Carmustine—malignant glioma	0.000626	0.0192	CcSEcCtD
Prasugrel—Haemoglobin—Temozolomide—malignant glioma	0.000617	0.0189	CcSEcCtD
Prasugrel—Haemorrhage—Temozolomide—malignant glioma	0.000614	0.0188	CcSEcCtD
Prasugrel—Urinary tract disorder—Temozolomide—malignant glioma	0.000606	0.0186	CcSEcCtD
Prasugrel—Oedema peripheral—Temozolomide—malignant glioma	0.000605	0.0185	CcSEcCtD
Prasugrel—Urethral disorder—Temozolomide—malignant glioma	0.000602	0.0184	CcSEcCtD
Prasugrel—Eye disorder—Carmustine—malignant glioma	0.000593	0.0182	CcSEcCtD
Prasugrel—Eye disorder—Temozolomide—malignant glioma	0.000574	0.0176	CcSEcCtD
Prasugrel—Angiopathy—Temozolomide—malignant glioma	0.000557	0.0171	CcSEcCtD
Prasugrel—Immune system disorder—Temozolomide—malignant glioma	0.000554	0.017	CcSEcCtD
Prasugrel—Mediastinal disorder—Temozolomide—malignant glioma	0.000553	0.0169	CcSEcCtD
Prasugrel—Back pain—Carmustine—malignant glioma	0.000535	0.0164	CcSEcCtD
Prasugrel—Back pain—Temozolomide—malignant glioma	0.000517	0.0158	CcSEcCtD
Prasugrel—Anaemia—Carmustine—malignant glioma	0.000511	0.0157	CcSEcCtD
Prasugrel—Leukopenia—Carmustine—malignant glioma	0.000495	0.0152	CcSEcCtD
Prasugrel—Anaemia—Temozolomide—malignant glioma	0.000494	0.0151	CcSEcCtD
Prasugrel—Angioedema—Temozolomide—malignant glioma	0.000488	0.015	CcSEcCtD
Prasugrel—Leukopenia—Temozolomide—malignant glioma	0.000478	0.0147	CcSEcCtD
Prasugrel—Hypertension—Carmustine—malignant glioma	0.000477	0.0146	CcSEcCtD
Prasugrel—Cough—Temozolomide—malignant glioma	0.000466	0.0143	CcSEcCtD
Prasugrel—Hypertension—Temozolomide—malignant glioma	0.000461	0.0141	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000452	0.0138	CcSEcCtD
Prasugrel—Thrombocytopenia—Carmustine—malignant glioma	0.000442	0.0135	CcSEcCtD
Prasugrel—Anaphylactic shock—Temozolomide—malignant glioma	0.000436	0.0134	CcSEcCtD
Prasugrel—Thrombocytopenia—Temozolomide—malignant glioma	0.000427	0.0131	CcSEcCtD
Prasugrel—Skin disorder—Temozolomide—malignant glioma	0.000424	0.013	CcSEcCtD
Prasugrel—Hypotension—Carmustine—malignant glioma	0.000422	0.0129	CcSEcCtD
Prasugrel—Dyspnoea—Carmustine—malignant glioma	0.000402	0.0123	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Carmustine—malignant glioma	0.00039	0.0119	CcSEcCtD
Prasugrel—Dyspnoea—Temozolomide—malignant glioma	0.000389	0.0119	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000376	0.0115	CcSEcCtD
Prasugrel—Fatigue—Temozolomide—malignant glioma	0.000376	0.0115	CcSEcCtD
Prasugrel—Body temperature increased—Carmustine—malignant glioma	0.000357	0.0109	CcSEcCtD
Prasugrel—Body temperature increased—Temozolomide—malignant glioma	0.000345	0.0106	CcSEcCtD
Prasugrel—Hypersensitivity—Carmustine—malignant glioma	0.000332	0.0102	CcSEcCtD
Prasugrel—Asthenia—Carmustine—malignant glioma	0.000324	0.00992	CcSEcCtD
Prasugrel—Hypersensitivity—Temozolomide—malignant glioma	0.000321	0.00984	CcSEcCtD
Prasugrel—Asthenia—Temozolomide—malignant glioma	0.000313	0.00958	CcSEcCtD
Prasugrel—Diarrhoea—Carmustine—malignant glioma	0.000309	0.00946	CcSEcCtD
Prasugrel—Dizziness—Carmustine—malignant glioma	0.000298	0.00914	CcSEcCtD
Prasugrel—Diarrhoea—Temozolomide—malignant glioma	0.000298	0.00914	CcSEcCtD
Prasugrel—Dizziness—Temozolomide—malignant glioma	0.000288	0.00883	CcSEcCtD
Prasugrel—Rash—Carmustine—malignant glioma	0.000284	0.00872	CcSEcCtD
Prasugrel—Dermatitis—Carmustine—malignant glioma	0.000284	0.00871	CcSEcCtD
Prasugrel—Headache—Carmustine—malignant glioma	0.000283	0.00866	CcSEcCtD
Prasugrel—Rash—Temozolomide—malignant glioma	0.000275	0.00842	CcSEcCtD
Prasugrel—Dermatitis—Temozolomide—malignant glioma	0.000275	0.00841	CcSEcCtD
Prasugrel—Headache—Temozolomide—malignant glioma	0.000273	0.00837	CcSEcCtD
Prasugrel—Nausea—Carmustine—malignant glioma	0.000268	0.00821	CcSEcCtD
Prasugrel—Nausea—Temozolomide—malignant glioma	0.000259	0.00793	CcSEcCtD
Prasugrel—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	4.86e-05	0.00057	CbGpPWpGaD
Prasugrel—ALB—Metabolism—COX8A—malignant glioma	4.84e-05	0.000567	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.77e-05	0.000559	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—H3F3A—malignant glioma	4.7e-05	0.000551	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP3—malignant glioma	4.69e-05	0.00055	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CB—malignant glioma	4.68e-05	0.000548	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	4.65e-05	0.000545	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN2B—malignant glioma	4.65e-05	0.000545	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	4.6e-05	0.000539	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BCAN—malignant glioma	4.59e-05	0.000539	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—RTEL1—malignant glioma	4.55e-05	0.000533	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTK2—malignant glioma	4.52e-05	0.000529	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CA—malignant glioma	4.51e-05	0.000529	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.5e-05	0.000527	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL8—malignant glioma	4.5e-05	0.000527	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HES1—malignant glioma	4.44e-05	0.00052	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.44e-05	0.00052	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NCOR1—malignant glioma	4.41e-05	0.000517	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—malignant glioma	4.37e-05	0.000512	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—RAF1—malignant glioma	4.35e-05	0.00051	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—COX8A—malignant glioma	4.34e-05	0.000509	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.32e-05	0.000507	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—IL2—malignant glioma	4.3e-05	0.000504	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	4.26e-05	0.000499	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CB—malignant glioma	4.25e-05	0.000498	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PDGFRA—malignant glioma	4.22e-05	0.000495	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ASMT—malignant glioma	4.11e-05	0.000482	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	4.11e-05	0.000482	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SPP1—malignant glioma	4.1e-05	0.000481	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	4.09e-05	0.000479	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL8—malignant glioma	4.08e-05	0.000479	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.02e-05	0.000471	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—COX8A—malignant glioma	3.96e-05	0.000464	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL2—malignant glioma	3.9e-05	0.000457	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TERT—malignant glioma	3.89e-05	0.000456	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.88e-05	0.000455	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KNG1—malignant glioma	3.88e-05	0.000454	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BCAN—malignant glioma	3.87e-05	0.000453	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA2—malignant glioma	3.8e-05	0.000445	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PDGFB—malignant glioma	3.79e-05	0.000445	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.78e-05	0.000443	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FGFR1—malignant glioma	3.77e-05	0.000442	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HIF1A—malignant glioma	3.72e-05	0.000436	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—IDH2—malignant glioma	3.7e-05	0.000434	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ASMT—malignant glioma	3.69e-05	0.000433	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—AKT1—malignant glioma	3.69e-05	0.000432	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.65e-05	0.000428	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.61e-05	0.000423	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SOD1—malignant glioma	3.6e-05	0.000422	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CAV1—malignant glioma	3.6e-05	0.000421	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.59e-05	0.000421	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.56e-05	0.000418	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KDR—malignant glioma	3.55e-05	0.000417	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.54e-05	0.000415	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BCAN—malignant glioma	3.47e-05	0.000407	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—F2—malignant glioma	3.42e-05	0.000401	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FN1—malignant glioma	3.42e-05	0.000401	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BAD—malignant glioma	3.38e-05	0.000396	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ASMT—malignant glioma	3.37e-05	0.000395	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH1—malignant glioma	3.35e-05	0.000393	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PTK2—malignant glioma	3.31e-05	0.000388	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.29e-05	0.000386	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CD80—malignant glioma	3.28e-05	0.000385	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CG—malignant glioma	3.27e-05	0.000384	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APC—malignant glioma	3.27e-05	0.000384	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	3.27e-05	0.000384	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGF—malignant glioma	3.24e-05	0.000379	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTPN11—malignant glioma	3.22e-05	0.000377	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—IDH1—malignant glioma	3.18e-05	0.000373	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BCAN—malignant glioma	3.17e-05	0.000371	CbGpPWpGaD
Prasugrel—ALB—Metabolism—IDH2—malignant glioma	3.12e-05	0.000365	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SPHK1—malignant glioma	3.08e-05	0.000361	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BRAF—malignant glioma	3.08e-05	0.000361	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2C18—malignant glioma	3.02e-05	0.000354	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT2—malignant glioma	3e-05	0.000351	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—malignant glioma	2.98e-05	0.00035	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.94e-05	0.000345	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2B6—malignant glioma	2.93e-05	0.000344	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CD—malignant glioma	2.88e-05	0.000337	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—malignant glioma	2.85e-05	0.000334	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—KRAS—malignant glioma	2.82e-05	0.00033	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—IDH2—malignant glioma	2.8e-05	0.000328	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.78e-05	0.000326	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PDGFB—malignant glioma	2.78e-05	0.000326	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FGF2—malignant glioma	2.76e-05	0.000323	CbGpPWpGaD
Prasugrel—ALB—Metabolism—IDH1—malignant glioma	2.68e-05	0.000314	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.64e-05	0.000309	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CAV1—malignant glioma	2.63e-05	0.000309	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.63e-05	0.000308	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—COX8A—malignant glioma	2.61e-05	0.000306	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SPHK1—malignant glioma	2.59e-05	0.000304	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—malignant glioma	2.59e-05	0.000304	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MDM2—malignant glioma	2.58e-05	0.000302	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RAF1—malignant glioma	2.57e-05	0.000301	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—IDH2—malignant glioma	2.55e-05	0.000299	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB2—malignant glioma	2.54e-05	0.000298	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2C18—malignant glioma	2.54e-05	0.000298	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CB—malignant glioma	2.51e-05	0.000294	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—F2—malignant glioma	2.51e-05	0.000294	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—FN1—malignant glioma	2.51e-05	0.000294	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTT1—malignant glioma	2.44e-05	0.000286	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—malignant glioma	2.41e-05	0.000283	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—IDH1—malignant glioma	2.41e-05	0.000282	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.41e-05	0.000282	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.4e-05	0.000281	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—malignant glioma	2.4e-05	0.000281	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.4e-05	0.000281	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EGF—malignant glioma	2.37e-05	0.000278	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PTPN11—malignant glioma	2.36e-05	0.000276	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—malignant glioma	2.33e-05	0.000273	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SPHK1—malignant glioma	2.33e-05	0.000273	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CASP3—malignant glioma	2.31e-05	0.000271	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—malignant glioma	2.3e-05	0.00027	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS1—malignant glioma	2.29e-05	0.000268	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.28e-05	0.000267	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ASMT—malignant glioma	2.22e-05	0.00026	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—IDH1—malignant glioma	2.19e-05	0.000257	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT2—malignant glioma	2.19e-05	0.000257	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.18e-05	0.000256	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—malignant glioma	2.18e-05	0.000256	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	2.17e-05	0.000255	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTEN—malignant glioma	2.17e-05	0.000254	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.15e-05	0.000252	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BCHE—malignant glioma	2.13e-05	0.000249	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SPHK1—malignant glioma	2.12e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—malignant glioma	2.12e-05	0.000248	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CD—malignant glioma	2.11e-05	0.000247	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.11e-05	0.000247	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.1e-05	0.000246	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BCAN—malignant glioma	2.09e-05	0.000245	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.08e-05	0.000244	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTT1—malignant glioma	2.06e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.96e-05	0.00023	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.96e-05	0.00023	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—malignant glioma	1.96e-05	0.00023	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—malignant glioma	1.94e-05	0.000227	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS1—malignant glioma	1.93e-05	0.000226	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.92e-05	0.000225	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.89e-05	0.000222	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAF1—malignant glioma	1.88e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTT1—malignant glioma	1.85e-05	0.000216	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CB—malignant glioma	1.84e-05	0.000215	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—malignant glioma	1.8e-05	0.000211	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BCHE—malignant glioma	1.79e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.79e-05	0.000209	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.77e-05	0.000208	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC5A5—malignant glioma	1.77e-05	0.000207	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—malignant glioma	1.76e-05	0.000207	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS1—malignant glioma	1.73e-05	0.000203	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.72e-05	0.000202	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.72e-05	0.000202	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—malignant glioma	1.69e-05	0.000198	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—malignant glioma	1.69e-05	0.000198	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—IDH2—malignant glioma	1.68e-05	0.000197	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—malignant glioma	1.68e-05	0.000197	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.67e-05	0.000196	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—malignant glioma	1.66e-05	0.000195	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.66e-05	0.000194	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAT—malignant glioma	1.65e-05	0.000193	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.63e-05	0.000191	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BCHE—malignant glioma	1.61e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.59e-05	0.000186	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.58e-05	0.000185	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS1—malignant glioma	1.58e-05	0.000185	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.57e-05	0.000184	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NCOR1—malignant glioma	1.56e-05	0.000182	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—malignant glioma	1.53e-05	0.000179	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.5e-05	0.000176	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.49e-05	0.000174	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—malignant glioma	1.48e-05	0.000173	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BCHE—malignant glioma	1.47e-05	0.000172	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.00017	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—IDH1—malignant glioma	1.45e-05	0.00017	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.45e-05	0.000169	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—malignant glioma	1.43e-05	0.000168	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—malignant glioma	1.42e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SPHK1—malignant glioma	1.4e-05	0.000164	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAT—malignant glioma	1.39e-05	0.000163	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.37e-05	0.000161	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.37e-05	0.00016	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.36e-05	0.000159	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NCOR1—malignant glioma	1.31e-05	0.000153	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.3e-05	0.000152	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—malignant glioma	1.28e-05	0.00015	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAV1—malignant glioma	1.27e-05	0.000149	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—malignant glioma	1.25e-05	0.000146	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAT—malignant glioma	1.24e-05	0.000146	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—malignant glioma	1.22e-05	0.000143	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.18e-05	0.000139	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NCOR1—malignant glioma	1.18e-05	0.000138	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—malignant glioma	1.17e-05	0.000137	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.15e-05	0.000135	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAT—malignant glioma	1.13e-05	0.000133	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—malignant glioma	1.12e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—malignant glioma	1.11e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—malignant glioma	1.11e-05	0.00013	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—malignant glioma	1.08e-05	0.000127	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NCOR1—malignant glioma	1.07e-05	0.000126	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAV1—malignant glioma	1.07e-05	0.000125	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS1—malignant glioma	1.04e-05	0.000122	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	0.00012	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.02e-05	0.000119	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—malignant glioma	9.72e-06	0.000114	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BCHE—malignant glioma	9.67e-06	0.000113	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAV1—malignant glioma	9.58e-06	0.000112	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.55e-06	0.000112	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—malignant glioma	9.38e-06	0.00011	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.15e-06	0.000107	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—malignant glioma	9.15e-06	0.000107	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—malignant glioma	8.85e-06	0.000104	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—malignant glioma	8.77e-06	0.000103	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAV1—malignant glioma	8.74e-06	0.000102	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—malignant glioma	8.73e-06	0.000102	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—malignant glioma	8.55e-06	0.0001	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—malignant glioma	8.42e-06	9.87e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.35e-06	9.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.96e-06	9.33e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—malignant glioma	7.69e-06	9.02e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—malignant glioma	7.68e-06	9e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.67e-06	8.99e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—malignant glioma	7.65e-06	8.96e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAT—malignant glioma	7.48e-06	8.77e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—malignant glioma	7.45e-06	8.73e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—malignant glioma	7.38e-06	8.65e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOR1—malignant glioma	7.07e-06	8.29e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—malignant glioma	7e-06	8.2e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.69e-06	7.84e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—malignant glioma	6.63e-06	7.77e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—malignant glioma	6.44e-06	7.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.1e-06	7.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—malignant glioma	6.04e-06	7.08e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—malignant glioma	5.78e-06	6.77e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAV1—malignant glioma	5.76e-06	6.75e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—malignant glioma	5.39e-06	6.32e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—malignant glioma	5.27e-06	6.18e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.25e-06	6.15e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—malignant glioma	5.06e-06	5.94e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.61e-06	5.41e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—malignant glioma	4.54e-06	5.32e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—malignant glioma	4.41e-06	5.17e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.08e-06	4.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.02e-06	4.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—malignant glioma	3.98e-06	4.67e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.72e-06	4.36e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—malignant glioma	3.71e-06	4.35e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—malignant glioma	3.47e-06	4.07e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—malignant glioma	3.33e-06	3.9e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—malignant glioma	3.04e-06	3.56e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.45e-06	2.87e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—malignant glioma	2e-06	2.35e-05	CbGpPWpGaD
